Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
2026-09-18
|
5-day change | 1st Jan Change | ||
| 0.000300 USD | -25.00% |
|
-25.00% | -88.46% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 58.55M 55.29M 50.21M 94.07M 6.44B 94.46M 662M 256M 3.28B 252M 247M 10.54B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 132M 125M 113M 212M 14.55B 213M 1.5B 577M 7.4B 570M 557M 23.81B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -25.00% | ||
| 1 week | -25.00% | ||
| Current month | -40.00% | ||
| 1 month | -62.50% | ||
| 3 months | -72.73% | ||
| 6 months | -92.50% | ||
| Current year | -88.46% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.05 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 8.22 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 2011-03-31 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 2022-02-28 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 2017-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -25.00% | -25.00% | -94.00% | -99.83% | 217K | |
| -0.31% | +5.79% | +48.93% | +97.53% | 70.89B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.32B | |
| -3.21% | -7.27% | -17.73% | +351.98% | 27.07B | |
| +0.50% | +7.13% | +29.43% | +15.48% | 26.2B | |
| -2.64% | -0.69% | -0.26% | -11.90% | 24.78B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.59B | |
| -1.26% | -7.81% | +169.33% | +302.38% | 15.52B | |
| -0.22% | +3.99% | +44.28% | +173.35% | 14.49B | |
| +0.73% | +1.71% | -7.18% | +886.19% | 14.14B | |
| Average | -3.03% | -0.91% | +24.09% | +178.05% | 27.6B | |
| Weighted average by Cap. | -0.49% | +1.49% | +36.35% | +148.21% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 46.13M 43.56M 39.56M 74.11M 5.08B 74.42M 522M 201M 2.58B 199M 194M 8.3B | 62.84M 54.8M 51.74M 46.98M 88.03M 6.03B 88.4M 620M 239M 3.07B 236M 231M 9.86B |
| Net income | -428M -373M -353M -320M -600M -41.1B -603M -4.22B -1.63B -20.9B -1.61B -1.57B -67.23B | -573M -500M -472M -428M -802M -54.97B -806M -5.65B -2.18B -27.95B -2.15B -2.1B -89.92B |
| Net Debt | 111M 96.53M 91.14M 82.76M 155M 10.62B 156M 1.09B 421M 5.4B 416M 407M 17.38B | 84.53M 73.71M 69.6M 63.2M 118M 8.11B 119M 834M 322M 4.12B 318M 310M 13.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$0.000300 | -25.00% | 116,109 |
| 26-09-17 | US$0.000400 | 0.00% | 40,687 |
| 26-09-16 | US$0.000400 | 0.00% | 79,548 |
| 26-09-15 | US$0.000400 | 0.00% | 88,787 |
| 26-09-14 | US$0.000400 | 0.00% | 64,522 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
